Brimonidine Tartrate & Timolol Maleate Ophthalmic Solution is a dual-action combination therapy formulated to effectively reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who require more intensive pressure control than single-agent therapy can provide.
Brimonidine Tartrate 0.2% w/v: An alpha-2 adrenergic agonist that reduces aqueous humor production and enhances uveoscleral outflow, helping lower eye pressure through two pathways.
Timolol Maleate 0.5% w/v: A beta-blocker that further decreases aqueous humor formation, providing additional pressure-lowering support.
Dual Mechanism for Stronger IOP Control: Targets intraocular pressure through complementary actions for superior results.
Ideal for Patients Not Controlled on Monotherapy: Provides added efficacy when single agents are insufficient.
Protects Against Optic Nerve Damage: Helps prevent long-term vision loss associated with uncontrolled glaucoma.
Clinically Trusted Ophthalmic Combination: Widely recommended for advanced glaucoma management.
Instill the prescribed number of drops into the affected eye(s), usually twice daily or as directed by an ophthalmologist. Avoid touching the dropper tip to maintain sterility.
May include mild burning or stinging, dry eyes, blurred vision, fatigue, or mild headache. Seek medical advice if symptoms persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Brimonidine Tartrate & Timolol Maleate sourced from reputed pharmaceutical manufacturers. Brimaglo-T is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.